192 related articles for article (PubMed ID: 19107739)
1. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
He H; Chen L; Zhai M; Chen JZ
Phytother Res; 2009 Jun; 23(6):868-73. PubMed ID: 19107739
[TBL] [Abstract][Full Text] [Related]
2. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
Singh S; Bhat MK
Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion.
Takada Y; Murakami A; Aggarwal BB
Oncogene; 2005 Oct; 24(46):6957-69. PubMed ID: 16007145
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
6. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
[TBL] [Abstract][Full Text] [Related]
7. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H
Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540
[TBL] [Abstract][Full Text] [Related]
8. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
9. Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Kim GY
Cancer Lett; 2008 Jun; 264(2):192-200. PubMed ID: 18314260
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor.
Sanda T; Iida S; Ogura H; Asamitsu K; Murata T; Bacon KB; Ueda R; Okamoto T
Clin Cancer Res; 2005 Mar; 11(5):1974-82. PubMed ID: 15756023
[TBL] [Abstract][Full Text] [Related]
11. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
Bharti AC; Donato N; Singh S; Aggarwal BB
Blood; 2003 Feb; 101(3):1053-62. PubMed ID: 12393461
[TBL] [Abstract][Full Text] [Related]
12. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
[TBL] [Abstract][Full Text] [Related]
13. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.
Wang X; Chen W; Lin Y
Biochem Biophys Res Commun; 2007 Apr; 355(3):807-12. PubMed ID: 17316570
[TBL] [Abstract][Full Text] [Related]
15. Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis.
Kim MO; Moon DO; Heo MS; Lee JD; Jung JH; Kim SK; Choi YH; Kim GY
Cancer Lett; 2008 Nov; 271(1):25-33. PubMed ID: 18602210
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
17. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
Khong T; Sharkey J; Spencer A
Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271
[TBL] [Abstract][Full Text] [Related]
18. The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity.
Nakaya A; Sagawa M; Muto A; Uchida H; Ikeda Y; Kizaki M
Leuk Res; 2011 Feb; 35(2):243-9. PubMed ID: 20542334
[TBL] [Abstract][Full Text] [Related]
19. SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation.
Sethi G; Ahn KS; Sung B; Kunnumakkara AB; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2008 Dec; 76(11):1404-16. PubMed ID: 18606397
[TBL] [Abstract][Full Text] [Related]
20. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
